These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29921453)

  • 21. Why hospice? The case for ESRD patients and their families.
    Soltys FG; Brookins M; Seney J
    ANNA J; 1998 Dec; 25(6):619-24, 578. PubMed ID: 10188398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing end of life care for patients with renal failure.
    Greaves C; Bailey E; Storey L; Nicholson A
    Nurs Stand; 2009 Sep 2-8; 23(52):35-41. PubMed ID: 19774780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal supportive care: view from across the pond: the United States perspective.
    Germain M; Cohen LM
    J Palliat Med; 2007 Dec; 10(6):1241-4. PubMed ID: 18095798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal technology advancing--but who will pay?
    Neumann ME
    Nephrol News Issues; 2005 May; 19(6):44. PubMed ID: 15945226
    [No Abstract]   [Full Text] [Related]  

  • 25. Ten myths and facts about hospice care.
    Labyak M
    Home Healthc Nurse; 2002 Mar; 20(3):148. PubMed ID: 11984173
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment modalities for ESRD patients. USRDS. United State Renal Data System.
    Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S54-66. PubMed ID: 9259693
    [No Abstract]   [Full Text] [Related]  

  • 27. ESRD quality assessment, assurance, improvement: a retrospective review and a look ahead.
    Burrows-Hudson S; Vlchek D
    Nephrol News Issues; 1997 Feb; 11(2):13-4, 62. PubMed ID: 9096456
    [No Abstract]   [Full Text] [Related]  

  • 28. CROWNWeb: system enhancements, the ESRD QIP, and things to come.
    Delva O
    Nephrol News Issues; 2013 Apr; 27(5):30-2. PubMed ID: 23638532
    [No Abstract]   [Full Text] [Related]  

  • 29. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.
    Collins AJ; Kasiske B; Herzog C; Chavers B; Foley R; Gilbertson D; Grimm R; Liu J; Louis T; Manning W; Matas A; McBean M; Murray A; St Peter W; Xue J; Fan Q; Guo H; Li S; Li S; Roberts T; Snyder J; Solid C; Wang C; Weinhandl E; Arko C; Chen SC; Dalleska F; Daniels F; Dunning S; Ebben J; Frazier E; Johnson R; Sheets D; Forrest B; Berrini D; Constantini E; Everson S; Frederick P; Eggers P; Agodoa L;
    Am J Kidney Dis; 2005 Jan; 45(1 Suppl 1):A5-7, S1-280. PubMed ID: 15640975
    [No Abstract]   [Full Text] [Related]  

  • 30. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001.
    Guo H; Kalra PA; Gilbertson DT; Liu J; Chen SC; Collins AJ; Foley RN
    Circulation; 2007 Jan; 115(1):50-8. PubMed ID: 17179020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular access creation and maintenance in the USA.
    Vachharajani N; Wise P; Klingensmith M; Jaques D; Shenoy S
    J Vasc Access; 2015; 16 Suppl 9():S1-4. PubMed ID: 25751542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospice and ESRD: knowledge deficits and underutilization of program benefits.
    Thompson KF; Bhargava J; Bachelder R; Bova-Collis R; Moss AH
    Nephrol Nurs J; 2008; 35(5):461-6, 502; quiz 467-8. PubMed ID: 18856076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The intersection of the Medicare end-stage renal disease (ESRD) benefit and hospice: an overview for home care and hospice clinicians.
    Castner D; Bednarski D
    Home Healthc Nurse; 2011 Sep; 29(8):464-76. PubMed ID: 21881427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Providers of ESRD therapy.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):89-92. PubMed ID: 1951361
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment modalities for ESRD patients. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S50-9. PubMed ID: 9713407
    [No Abstract]   [Full Text] [Related]  

  • 36. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 37. End-stage renal disease (ESRD) and its treatment in Japan.
    Tsukamoto Y
    Nephrol Dial Transplant; 2008 Aug; 23(8):2447-50. PubMed ID: 18469312
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantity and quality of ESRD treatment in the United States of America.
    Sadler J
    Contrib Nephrol; 1990; 78():181-5. PubMed ID: 2225835
    [No Abstract]   [Full Text] [Related]  

  • 39. International comparisons of ESRD therapy.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):93-5. PubMed ID: 1951362
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving Outcomes in Patients Receiving Dialysis: The Peer Kidney Care Initiative.
    Wetmore JB; Gilbertson DT; Liu J; Collins AJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1297-1304. PubMed ID: 27006497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.